Last update May 20, 2025

C22H23NO7

Compatible

Safe product and/or breastfeeding is the best option.

Centrally acting cough suppressant with properties and uses similar to dextromethorphan. Oral or rectal administration in three daily doses. 

Its high protein binding rate (Karlsson 1990) explains the very low passage into milk observed. (Olsson 1986)

In addition, its low oral bioavailability (Dahlström 1982) makes it difficult to pass into infant plasma from ingested breast milk.

American Academy of Pediatrics: medication usually compatible with breastfeeding. (AAP 2001)

Alternatives

We do not have alternatives for C22H23NO7 since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Other names

C22H23NO7 is Noscapine in Molecular formula.

Is written in other languages:

C22H23NO7 is also known as

Group

C22H23NO7 belongs to this group or family:

Tradenames

Main tradenames from several countries containing C22H23NO7 in its composition:

List of 24 tradenames

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 30 %
Molecular weight 413 daltons
Protein Binding 93 %
VD 4.7 l/Kg
Tmax 2.5 hours
T½ 2.6 - 4.5 hours
M/P ratio 0.15 - 0.88 -
Theoretical Dose 0.002 - 0.01 mg/Kg/d
Relative Dose 0.07 - 0.8 %

References

  1. AAP - American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 2001 Sep;108(3):776-89. Abstract Full text (link to original source) Full text (in our servers)
  2. Karlsson MO, Dahlström B, Eckernäs SA, Johansson M, Alm AT. Pharmacokinetics of oral noscapine. Eur J Clin Pharmacol. 1990 Abstract
  3. Karlsson MO, Dahlström B. Serum protein binding of noscapine: influence of a reversible hydrolysis. J Pharm Pharmacol. 1990 Abstract
  4. Olsson B, Bolme P, Dahlström B, Marcus C. Excretion of noscapine in human breast milk. Eur J Clin Pharmacol. 1986 Abstract
  5. Dahlström B, Mellstrand T, Löfdahl CG, Johansson M. Pharmacokinetic properties of noscapine. Eur J Clin Pharmacol. 1982 Abstract

Total visits

2,193

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by La Liga de la Leche, España of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM